Genentech Singapore to acquire cell culture biologic manufacturing facility form Lonza - MarketLine Financial Deals

Genentech Singapore to acquire cell culture biologic manufacturing facility form Lonza

Genentech Singapore to acquire cell culture biologic manufacturing facility form Lonza - MarketLine Financial Deals
Genentech Singapore to acquire cell culture biologic manufacturing facility form Lonza
Published Aug 31, 2009
2 pages — Published Aug 31, 2009
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Genentech Singapore Pte., Ltd., a wholly-owned subsidiary of Roche Holding, Ltd., has agreed to acquire the Singapore-based cell culture biologic manufacturing facility form Lonza Group, Ltd. for a consideration of $290 million plus additional milestone payments of $70 million.

  
Source:
Document ID
MA08335_090901
Country
Country
Ticker
LONN=CH
Ticker
ROG=CH
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Genentech Singapore to acquire cell culture biologic manufacturing facility form Lonza" Aug 31, 2009. Alacra Store. Dec 07, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Genentech-Singapore-to-acquire-cell-culture-biologic-manufacturing-facility-form-Lonza-2052-8039>
  
APA:
MarketLine Financial Deals. (2009). Genentech Singapore to acquire cell culture biologic manufacturing facility form Lonza Aug 31, 2009. New York, NY: Alacra Store. Retrieved Dec 07, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Genentech-Singapore-to-acquire-cell-culture-biologic-manufacturing-facility-form-Lonza-2052-8039>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.